GMOV Among Value ETFs
End-of-day Nov 20, 2026 · 83 Value ETFs by Max
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.5% | −6.7% | −6.5% | −4.4% | +15.2% | +21.6% | — | — | — | +30.5% |
| Peer average | −1.9% | −6.5% | −5.7% | −6.2% | +11.4% | +17.2% | +59.4% | +59.5% | +190.3% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$73 of every $1,000 in GMOV is Microsoft
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MSFTMicrosoft | Technology | 7.32% | $731.60 | 14K | $6.9M |
| 2 | METAMETA Platforms | Communication Services | 5.25% | $525.05 | 8,335 | $5.0M |
| 3 | XOMExxonmobil | Energy | 3.83% | $382.75 | 23K | $3.6M |
| 4 | VZVerizon Communications | Communication Services | 2.55% | $254.76 | 53K | $2.4M |
| 5 | PFEPfizer | Healthcare | 2.38% | $237.60 | 82K | $2.2M |
| 6 | JPMJpmorgan Chase + | Financial Services | 2.23% | $223.09 | 6,594 | $2.1M |
| 7 | REGNRegeneron Pharmaceuticals | Healthcare | 2.14% | $214.11 | 2,197 | $2.0M |
| 8 | MRKMerck + | Healthcare | 2.08% | $208.14 | 15K | $2.0M |
| 9 | BACBank OF America | Financial Services | 2.01% | $201.45 | 39K | $1.9M |
| 10 | BMYBristol Myers Squibb | Healthcare | 2.01% | $201.30 | 33K | $1.9M |
| 11 | ADBEAdobe | Technology | 1.93% | $193.06 | 8,243 | $1.8M |
| 12 | CITHE Cigna Group | Healthcare | 1.89% | $188.96 | 6,550 | $1.8M |
| 13 | CVSCVS Health | Healthcare | 1.85% | $185.09 | 22K | $1.8M |
| 14 | ALLAllstate | Financial Services | 1.85% | $184.81 | 6,557 | $1.7M |
| 15 | PGRProgressive | Financial Services | 1.85% | $184.80 | 7,606 | $1.7M |
of the $465B in 83 Value ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MSFT | Microsoft | 7.32% |
| 2 | META | META Platforms | 5.25% |
| 3 | XOM | Exxonmobil | 3.83% |
| 4 | VZ | Verizon Communications | 2.55% |
| 5 | PFE | Pfizer | 2.38% |
| 6 | JPM | Jpmorgan Chase + | 2.23% |
| 7 | REGN | Regeneron Pharmaceuticals | 2.14% |
| 8 | MRK | Merck + | 2.08% |
| 9 | BAC | Bank OF America | 2.01% |
| 10 | BMY | Bristol Myers Squibb | 2.01% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 30, 2026 | Oct 1, 2026 | $0.17 |
| Jun 30, 2026 | Jul 1, 2026 | $0.13 |
| Mar 31, 2026 | Apr 1, 2026 | $0.17 |
| Dec 30, 2025 | Dec 31, 2025 | $0.14 |
| Sep 30, 2025 | Oct 1, 2025 | $0.15 |
| Jul 1, 2025 | Jul 2, 2025 | $0.15 |
| Mar 31, 2025 | Apr 1, 2025 | $0.10 |
| Dec 30, 2024 | Dec 31, 2024 | $0.0732 |